536
Participants
Start Date
July 31, 2019
Primary Completion Date
November 26, 2024
Study Completion Date
March 15, 2027
Laboratory Biomarker Analysis
Correlative studies
Recombinant Human Papillomavirus Nonavalent Vaccine
Given IM
Saline
Given IM
Moi University School of Medicine, Eldoret
UNC Project Malawi, Lilongwe
African Cancer Institute at Stellenbosch, Cape Town
University of the Witwatersrand, Johannesburg
Uganda Cancer Institute, Kampala
University of Zimbabwe, Harare
National Cancer Institute (NCI)
NIH
University of Arkansas
OTHER
AIDS and Cancer Specimen Resource
OTHER
Merck Sharp & Dohme LLC
INDUSTRY
The Emmes Company, LLC
INDUSTRY
University of California, Los Angeles
OTHER
AIDS Malignancy Consortium
NETWORK